The RFP Database
New business relationships start here

Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program

Colorado, United States
Government : Military
Go to the link
This document has expired, therefore the above link may no longer work.

The Department of Defense (DoD) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoD Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoD Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ.

P&T COMMITTEE MEETING: November 2019: The following drug classes/subclass and newly approved agents will be reviewed:
Urinary Agents Miscellaneous, SUB CLASS:  NA - Thiola EC

Oncological Agents, SUB CLASS:  Multiple Myeloma - Xpovio

GI-2 Agents, SUB CLASS:  CIC and IBS-C - Zelnorm

Contraceptive Agents, SUB CLASS:  Miscellaneous - Annovera

Binders Chelators Antidotes Overdose, SUB CLASS:  NA- Baqsimi

Calcium Channel Blocking Agents, SUB CLASS:  NA - Katerzia

Oncological Agents, SUB CLASS:  2nd-Gen Antiandrogens - Nubeqa

RFQ: The RFQ, including UF BPA and UF ADP appendices are attached herein.
There is no pre-proposal teleconference. Rather, questions shall be submitted via e-mail to the Request for Quote (RFQ) Point of Contact stated in Part 2.3, no later than the date stated in Part 2.4. Also, responses to Part 3.4 is required.

POCs: Part 2.3 of the RFQ.

For additional information, search DoD Pharmacy and Therapeutics (P&T) Committee at

Alexia Ray, Contract Analyst, CTR, Phone 2105366020, Email - Yvette H. Dluhos, Contract Specialist, Phone 210-536-6048, Email

    1. Home
    2. Articles
    3. Login or Register

    4. Search

    5. Add/Announce your RFP